Gene regulatory effects of Ginkgo biloba extract and its flavonol and terpenelactone fractions in mouse brain

Journal of Clinical Biochemistry and Nutrition

Volumn 45, Issue 3, 2009, Pages 315-321

  Augustin, Sabine ^a   Rimbach, Gerald ^a   Augustin, Kay ^a   Cermak, Rainer ^b   Wolffram, Siegfried ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Alzheimer's disease; Amyloid beta precursor protein; Flavonols; Ginkgo biloba; Terpenelactones

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN BINDING PROTEIN 1; BILOBALIDE; BINDING PROTEIN; FLAVONOL; GINKGO BILOBA EXTRACT; GINKGOLIDE A; GINKGOLIDE B; GINKGOLIDE C; ISORHAMNETIN; KAEMPFEROL; LACTONE DERIVATIVE; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; QUERCETIN; TERPENELACTONE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL;

GINKGO BILOBA; MUS;

EID: 70549108840     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.08-248     Document Type: Article

References (35)

1. Cermak, R. and Wolffram, S.: Effect of Ginkgo biloba extract EGb761 on differential gene expression in the brain, in Nutrigenomics - The role of oxidants and antioxidants in differential gene expression, eds. By Rimbach, G. and J.F.a.L.P., CRC Press, Taylor & Francis Group, Boca Raton, pp. 341-352, 2005.
2. DeFeudis, F.V. and Drieu, K.: Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr. Drug Targets, 1, 25-58, 2000.
3. Christen, Y.: Ginkgo biloba and neurodegenerative disorders. Front. Biosci., 9, 3091-3104, 2004.
4. Sierpina, V.S., Wollschlaeger, B., and Blumenthal, M.: Ginkgo biloba. Am. Fam. Physician, 68, 923-926, 2003.
5. Bastianetto, S., Zheng, W.H., and Quirion, R.: The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity. Involvement of its flavonoid constituents and protein kinase C. J. Neurochem., 74, 2268-2277, 2000.
6. Chandrasekaran, K., Mehrabian, Z., Spinnewyn, B., Chinopoulos, C., Drieu, K., and Fiskum, G.: Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death. Pharmacopsychiatry, 36, S89-S94, 2003.
7. De Feudis, F.V.: Effects of Ginkgo biloba extract (EGb 761) on gene expression: Possible relevance to neurological disorders and age-associated cognitive impairment. Drug Dev. Res., 57, 214-235, 2008.
8. De Feudis, F.V.: Bilobalide and neuroprotection. Pharmacol. Res., 46, 565-568, 2002.
9. Ahlemeyer, B. and Krieglstein, J.: Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease. Pharmacopsychiatry, 36, S8-S14, 2003.
10. Klein, J., Weichel, O., Hilgert, M., Rupp, J., Chatterjee, S.S., and Nawrath, H.: Excitotoxic hippocampal membrane breakdown and its inhibition by bilobalide: role of chloride fluxes. Pharmacopsychiatry, 36, S78-S83, 2003. (Pubitemid 37047013)
11. Watanabe, C.M.H., Wolffram, S., Ader, P., Rimbach, G., Packer, L., Maguire, J.J., Schultz, P.G., and Gohil, K.: The in vivo neuromodulator effects of the herbal medicine ginkgo biloba. Proc. Natl. Acad. Sci. USA, 98, 6577-6580, 2001.
12. Tsuzuki, K., Fukatsu, R., Yamaguchi, H., Tateno, M., Imai, K., Fujii, N., and Yamauchi, T.: Transthyretin binds amyloid [beta] peptides, A[beta]1-42 and A[beta]1-40 to form complex in the autopsied human kidney - possible role of transthyretin for A[beta] sequestration. Neurosci. Lett., 281, 171-174, 2000.
13. Choi, S.H., Leight, S.N., Lee, V.M.Y., Li, T., Wong, P.C., Johnson, J.A., Saraiva, M.J., and Sisodia, S.S.: Accelerated Aβ Deposition in APPswe/PS1ΔE9 Mice with Hemizygous Deletions of TTR (Transthyretin). J. Neurosci., 27, 7006-7010, 2007.
14. De Strooper, B. and Annaert, W.: Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci., 113, 1857-1870, 2000.
15. Apelt, J., Ach, K., and Schliebs, R.: Aging-related down-regulation of neprilysin, a putative [beta]-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of β-amyloid plaques. Neurosci. Lett., 339, 183-186, 2003.
16. Chen, Y., Liu, W., McPhie, D.L., Hassinger, L., and Neve, R.L.: APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain. J. Cell Biol., 163, 27-33, 2003. (Pubitemid 37271431)
17. Iwata, N., Higuchi, M., and Saido, T.C.: Metabolism of amyloid-[beta] peptide and Alzheimer's disease. Pharmacol. Ther., 108, 129-148, 2005.
18. Burns, A. and O'Brien, J.: Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J. Psychopharmacol., 20, 732-755, 2006. (Pubitemid 44622739)
19. Augustin, S., Huebbe, P., Matzner, N., Augustin, K., Schliebs, R., Cermak, R., Wolffram, S., and Rimbach, G.: Ginkgo biloba extract and its flavonol and terpenelactone fractions do not affect β-secretase mRNA and enzyme activity levels in cultured neurons and in mice. Planta Med., 1, 6-13, 2008.
20. Ader, P., Wessmann, A., and Wolffram, S.: Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic. Biol. Med., 28, 1056-1067, 2000.
21. Fourtillan, J.B., Brisson, A.M., Girault, J., Ingrand, I., Decourt, J.P., Drieu, K., Jouenne, P., and Biber, A.: Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761). Therapie, 50, 137-144, 1995.
22. Biber, A. and Koch, E.: Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC/MS. Planta Med., 65, 192-193, 1999. (Pubitemid 29138164)
23. Biber, A.: Pharmacokinetics of Ginkgo biloba extracts. Pharmacopsychiatry, 36, S32-S37, 2003.
24. de Boer, V.C., Dihal, A.A., van der Woude, H., Arts, I.C., Wolffram, S., Alink, G.M., Rietjens, I.M., Keijer, J., and Hollman, P.C.: Tissue distribution of quercetin in rats and pigs. J. Nutr., 135, 1718-1725, 2005. (Pubitemid 40980724)
25. Bastianetto, S., Ramassamy, C., Dore, S., Christen, Y., Poirier, J., and Quirion, R.: The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur. J. Neurosci., 12, 1882-1890, 2000.
26. Luo, Y., Smith, J.V., Paramasivam, V., Burdick, A., Curry, K.J., Buford, J.P., Khan, I., Netzer, W.J., Xu, H., and Butko, P.: Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc. Natl. Acad. Sci. USA, 99, 12197-12202, 2002.
27. Luo, C., Wu, Q., Huang, X.N., Sun, A.S., and Shi, J.S.: Ginkgo biloba leaf extract enhances levels of caspase-3 and amyloid precursor protein in normal rat hippocampus. Acta Pharmacol. Sin., 24, 152-156, 2003.
28. Yao, Z.-X., Zeqiu, H., Katy, D., and Vassilios, P.: Ginkgo biloba extract (Egb 761) inhibits β-amyloid production by lowering free cholesterol levels. J. Nutr. Biochem., 15, 749-756, 2004.
29. Liu, L. and Murphy, R.M.: Kinetics of Inhibition of β-Amyloid Aggregation by Transthyretin. Biochemistry, 45, 15702-15709, 2006.
30. Stein, T.D. and Johnson, J.A.: Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J. Neurosci., 22, 7380-7388, 2002.
31. Buxbaum, J.N., Ye, Z., Reixach, N., Friske, L., Levy, C., Das, P., Golde, T., Masliah, E., Roberts, A.R., and Bartfai, T.: Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity. Proc. Natl. Acad. Sci. USA, 105, 2681-2686, 2008.
32. Richardson, S.J.: Cell and Molecular Biology of Transthyretin and Thyroid Hormones. International Review of Cytology. Academic Press, pp. 137-193, 2007.
33. Sousa, J.C., Cardoso, I., Marques, F., Saraiva, M.J., and Palha, J.A.: Transthyretin and Alzheimer's disease: Where in the brain? Neurobiol. Aging, 28, 713-718, 2007. (Pubitemid 46349354)
34. Augustin, S., Rimbach, G., Augustin, K., Schliebs, R., Wolffram, S., and Cermak, R.: Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease. Arch. Biochem. Biophys., 481, 177-182, 2009.
35. Williams, B., Watanabe, C.M.H., Schultz, P.G., Rimbach, G., and Krucker, T.: Age-related effects of Ginkgo biloba extract on synaptic plasticity and excitability. Neurobiol. Aging, 25, 955-962, 2008.